Before performing phase II/III clinical trials in Africa, preliminary studies, including assessment and building up of clinical and laboratory infrastructures, estimates of human immunodeficiency virus incidence, investigation of the background immune response, and evaluation of the cross-clade immune response, need to be done. Plans and ongoing work in the context of the AIDS Vaccine Integrated Project and some preliminary data are presented.
Preparing for Phase II/III HIV vaccine trials in Africa / E. Vardas, S. Buttò, R. Glashoff, P. Lusso, M.S. Malnati, G. Poli, M. Clerici. - In: MICROBES AND INFECTION. - ISSN 1286-4579. - 7:14(2005), pp. 1436-1444.
Preparing for Phase II/III HIV vaccine trials in Africa
M. ClericiUltimo
2005
Abstract
Before performing phase II/III clinical trials in Africa, preliminary studies, including assessment and building up of clinical and laboratory infrastructures, estimates of human immunodeficiency virus incidence, investigation of the background immune response, and evaluation of the cross-clade immune response, need to be done. Plans and ongoing work in the context of the AIDS Vaccine Integrated Project and some preliminary data are presented.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
